TAFINLAR DISPERSIBLE TABLET 10MG
Product details
Registration number: SIN17019P
Classification: Prescription Only
Active ingredients: Dabrafenib mesylate eqv Dabrafenib
Strength: 10mg
Dosage form: TABLET, FOR SUSPENSION
Route: ORAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: L01EC02
HSA approval date: 3 June 2024
Manufacturer(s): Novartis Pharma Stein AG
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for TAFINLAR DISPERSIBLE TABLET 10MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17019P
Classification: Prescription Only
What active ingredients and strength are recorded for TAFINLAR DISPERSIBLE TABLET 10MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Dabrafenib mesylate eqv Dabrafenib
Strength: 10mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TAFINLAR DISPERSIBLE TABLET 10MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for TAFINLAR DISPERSIBLE TABLET 10MG?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for TAFINLAR DISPERSIBLE TABLET 10MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Novartis Pharma Stein AG
Manufacturing country/countries: SWITZERLAND
Where can I look up TAFINLAR DISPERSIBLE TABLET 10MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17019P or the exact product name TAFINLAR DISPERSIBLE TABLET 10MG. The general register link does not preselect this product.
What are the source dates for this TAFINLAR DISPERSIBLE TABLET 10MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TAFINLAR DISPERSIBLE TABLET 10MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17019P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)